Health ❯Healthcare ❯Clinical Trials

Efficacy Studies

Phase 3 Trials Lecanemab SUMMIT Trial Lecanemab Trials Lecanemab Efficacy Lecanemab Trial Results Miplyffa Home Treatment Options Non-Inferiority Trials Hormone Receptor-Positive Cancer Drug Comparisons Weight Loss Outcomes Amycretin Trials mNEXSPIKE Vaccine Simplify-1 Study SELECT Trial Results Phase IIb/III Trials CAPELLA Trial

Novo Nordisk’s Amycretin Delivers Up to 24% Early Weight Loss in Dual-Form Trials

The trial results highlight amycretin’s potential to simplify long-term obesity treatment through injectable or oral formulations.

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations

NICE Approves Capivasertib for NHS Use in Advanced Breast Cancer Treatment

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Home Brain Stimulation Headset Shows Promise in Treating Depression

FDA Approves First Treatment for Niemann-Pick Disease Type C

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients